CLINICAL_TRIALS trial_result · 2020-05-13

Clinical Trial Update: A Safety Study of SYNT001 in Participants With Warm Autoimmune Hemolytic Anemia (WAIHA) [Phase 1, Phase 2]

Summary

A safety study of SYNT001 in participants with Warm Autoimmune Hemolytic Anemia (WAIHA)—terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

Snippet

Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Warm Autoimmune Hemolytic Anemia | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2020-05-13